Committed to sharing our science

Committed to sharing our science

341 results available

Effect of the Cardiac Myosin Activator Omecamtiv Mecarbil on Risk of Ventricular Arrhythmias in Heart Failure with Reduce

Oral Presentation, AHA 2024

Foà, A et al.

November 16, 2024
Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure with Reduced Ejection Fraction According to Age: the GALACTIC-HF Trial

Poster, AHA 2024

Lu, H et al.

November 18, 2024
Association of Sociodemographic Characteristics on Costs of Care in Patients with Obstructive Hypertrophic Cardiomyopathy

Poster, AHA 2024

Reza, N et al

November 17, 2024
Efficacy and Safety of Aficamten in Patients Guideline-Eligible for Septal Reduction Therapy in the FOREST-HCM Trial

Poster, AHA 2024

Masri, A et al

November 17, 2024
Clinicoeconomic Burden Among Heart Failure Patients With Severely Reduced Ejection Fraction After Hospital Admission: HF-RESTORE

European Heart Journal – Quality of Care and Clinical Outcomes

May, HT et al

September 30, 2024